Company intelligence / Profile preview

Colorimetrix

Ownership: Private
Development stage: Other

Overview

No clinical results published. The technology enables semi‑quantitative measurement of a wide range of analytes by digitizing traditional colorimetric assays with a smartphone app. The company claims accuracy suitable for remote diagnostics in various settings but does not provide peer-reviewed validation data.

Therapeutic areas: Metabolic DisordersWomen's HealthInfectious DiseasesEndocrinologyOtherNephrologyCardiovascular
Modalities: DeviceDigital diagnostic tool
Industry: Metabolite Diagnostics

Beyond the preview

Go deeper on Colorimetrix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Colorimetrix.

Explore the full profile